Extreme Movers: Perplexity's picks for 2026-10-12

Perplexity picked CCI, MRNA, HUM, TMUS, T for a 1-day horizon. Average directional return: +1.38%. Directions called correctly: 100%.

ExperimentExtreme Movers
ModelPerplexity
Prompt versionextreme-movers-v11
Asked
Horizon1-day
Measured from2026-10-12
Measured to2026-10-13
BenchmarkSPY
StatusSettled
Average directional return+1.38%
Directions called correctly100%
Benchmark return-0.30%

The picks

RankSymbolDirectionPrice changeReturn in the called directionConfidencevs benchmarkCalled right
1CCIdown-0.25%+0.25%55%+0.55%Yes
2MRNAdown-1.44%+1.44%50%+1.74%Yes
3HUMdown-1.94%+1.94%50%+2.24%Yes
4TMUSup+0.82%+0.82%55%+1.12%Yes
5Tup+2.44%+2.44%50%+2.75%Yes

The model's market view

The source session was Friday, October 9, 2026, when SpaceX's nationwide low-band spectrum acquisition triggered a sharp telecom-infrastructure rotation: tower REITs rallied while wireless carriers and satellite-connectivity names sold off. With the next session opening after a holiday-thinned tape and ahead of bank earnings, I favor partial mean reversion in the largest one-day moves rather than unconditional continuation, while recognizing that the SpaceX catalyst may keep pressuring carriers.

Why each pick

CCI

Crown Castle was the largest S&P 500 gainer in the October 9 source session, rising 15.60% to $79.64 after SpaceX's spectrum deal was read as supportive for tower-leasing demand. The catalyst is substantive but already produced an outsized one-day repricing; I expect some reversal lower as the initial news premium is digested. Reference price is the latest quote found, $79.80 on October 12, 2026; market cap and 20-day dollar volume were verified from quote pages showing a $33.88-34.65 billion market cap and roughly 3.78-4.59 million average daily shares, implying well over $20 million in daily dollar volume.

MRNA

Moderna gained 14.21% in the source session, closing at $225.00, on an NIH cancer-vaccine initiative and index-inclusion-driven biotech enthusiasm. The catalyst appears partly speculative and event-driven rather than a confirmed near-term earnings change, so I expect a reversal lower after the outsized advance. The latest quote found was $225.47 on October 12, 2026; market cap was about $89.82 billion and average volume 19.21 million shares, comfortably clearing the liquidity floor.

HUM

Humana rose 11.56% to $431.87 in the October 9 session after improved Medicare Advantage star ratings and analyst upgrades reset earnings expectations. This is a more fundamental catalyst than a purely speculative move, but the size of the single-day gain argues for partial reversal. The latest quote found was $438.49, dated October 11, 2026 on the quote snapshot; market cap was about $51.85 billion and average volume 1.94 million shares, implying roughly $850 million of daily dollar volume.

TMUS

T-Mobile US fell 13.27% to $148.58 in the source session after SpaceX's spectrum acquisition and store-closure plans refocused investors on competitive risk. The threat is substantive, but the decline was exceptionally large for a mega-cap carrier and the stock was indicated about 1.15% higher in the October 12 premarket; I expect a partial reversal higher. The latest quote found was $148.76 on October 12, 2026; market cap was about $159.39 billion and average volume 5.63 million shares, implying roughly $838 million of daily dollar volume.

T

AT&T declined 9.70% to $22.18 in the October 9 source session on SpaceX-related competitive concerns, an ex-dividend date, and an Oppenheimer downgrade. The fundamental concern is real, but the move was severe for a large, dividend-paying telecom and the stock was indicated modestly higher in the October 12 premarket; I expect a partial reversal higher. The latest quote found was $22.24 in premarket trading on October 12, 2026; market cap was about $151.99 billion and average volume roughly 49.69 million shares, implying more than $1.1 billion of daily dollar volume.

Other models on the same run

ModelPicksAverage directional returnDirections called correctly
Muse Spark 1.1HUM, CCI, MRNA, TMUS, T-0.95%40%
Gemini 1.5 ProCCC, TRAX, BIIB, BE, IONQ-0.04%60%
Grok 4.5CCC, FIGS, TTMI, CIEN, LITE+2.92%100%
DeepSeekMETA, FIGS, WOLF, SNDK, MU-0.82%40%
GPT-6TMUS, FSLY, NVAX, HUM, CCI-0.29%60%

Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-12.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.